GENE ONLINE|News &
Opinion
Blog

PAXLOVID
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
Pfizer’s COVID-19 Oral Antiviral Cuts Hospitalization and Death By 89%
2021-11-05
LATEST
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
Key Market Trends Shaping Health Systems and Specialty Pharmacies
2025-01-08
COVID Caused Cancer Tumors to Shrink in Mice and We Want to Know How
2025-01-08
Catapulting Stem Cell Research into the Future: Innovation and Global Impact at ISSCR 2025 in Hong Kong
2025-01-08
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
Scroll to Top